Therefore, the finding that the in vitro-generated CD4+ T cells are cytotoxic suggests that the vaccination-induced T cell response comprises CD4+ T cells with killing capacity towards RhoC, at least as judged by in vitro assays using class II-expressing cancer cells as targets. The gene discussed is CD4; the disease is cancer.